```{r include_packages_2, include = FALSE}
# This chunk ensures that the thesisdown package is
# installed and loaded. This thesisdown package includes
# the template files for the thesis and also two functions
# used for labeling and referencing
if (!require(remotes)) {
  if (params$`Install needed packages for {thesisdown}`) {
    install.packages("remotes", repos = "https://cran.rstudio.com")
  } else {
    stop(
      paste(
        'You need to run install.packages("remotes")',
        "first in the Console."
      )
    )
  }
}
if (!require(dplyr)) {
  if (params$`Install needed packages for {thesisdown}`) {
    install.packages("dplyr", repos = "https://cran.rstudio.com")
  } else {
    stop(
      paste(
        'You need to run install.packages("dplyr")',
        "first in the Console."
      )
    )
  }
}
if (!require(ggplot2)) {
  if (params$`Install needed packages for {thesisdown}`) {
    install.packages("ggplot2", repos = "https://cran.rstudio.com")
  } else {
    stop(
      paste(
        'You need to run install.packages("ggplot2")',
        "first in the Console."
      )
    )
  }
}
if (!require(bookdown)) {
  if (params$`Install needed packages for {thesisdown}`) {
    install.packages("bookdown", repos = "https://cran.rstudio.com")
  } else {
    stop(
      paste(
        'You need to run install.packages("bookdown")',
        "first in the Console."
      )
    )
  }
}
if (!require(thesisdown)) {
  if (params$`Install needed packages for {thesisdown}`) {
    remotes::install_github("ismayc/thesisdown")
  } else {
    stop(
      paste(
        "You need to run",
        'remotes::install_github("ismayc/thesisdown")',
        "first in the Console."
      )
    )
  }
}
library(thesisdown)
library(dplyr)
library(ggplot2)
library(knitr)
flights <- read.csv("data/flights.csv", stringsAsFactors = FALSE)
```

# Analysis of Individual patient Data {#ref-labels}

<br>
<br>

## Mok et al. 2009 IPASS Study: Crossing Hazards

<br>
<br>

```{r, echo=FALSE, warning=FALSE, message=FALSE, fig.cap="Overall Study Results"}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

km_trt_fit <- survfit(Surv(time, event) ~ arm, data = IPD.Mok.A)

ggsurv <- ggsurvplot(
  km_trt_fit,                     # survfit object with calculated statistics.
  data = IPD.Mok.A,             # data used to fit survival curves.
  risk.table = TRUE,       # show risk table.
  pval = FALSE,             # show p-value of log-rank test.
  conf.int = FALSE,         # show confidence intervals for 
  # point estimates of survival curves.
  palette = c("#E7B800", "#2E9FDF"),
  xlim = c(0,20),         # present narrower X axis, but not affect
  # survival estimates.
  xlab = "Months since Randomization",   # customize X axis label.
  ylab = "Pr of Progression-free Survival",   # customize X axis label.
  break.time.by = 4,     # break X axis in time intervals by 500.
  ggtheme = theme_light(), # customize plot and risk table with a theme.
  risk.table.y.text.col = T,# colour risk table text annotations.
  risk.table.height = 0.25, # the height of the risk table
  risk.table.y.text = FALSE,# show bars instead of names in text annotations
  # in legend of risk table.
  ncensor.plot = FALSE,      # plot the number of censored subjects at time t
  ncensor.plot.height = 0.25,
  conf.int.style = "step",  # customize style of confidence intervals
  surv.median.line = "hv",  # add the median survival pointer.
  legend.labs = c("Carboplatin", "Gefitinib")    # change legend labels.
)

# Labels for Survival Curves (plot)
ggsurv$plot <- ggsurv$plot + labs(
  title    = "Kaplan-Meier Curves for Progression-free Survival",                  
  subtitle = "Overall Study Results"
)

# Changing the font size, style and color

ggsurv <- ggpar(
  ggsurv,
  font.title    = c(16, "bold", "black"),         
  font.subtitle = c(10, "bold.italic", "black"), 
  font.caption  = c(14, "plain", "black"),        
  font.x        = c(14, "bold.italic", "black"),          
  font.y        = c(14, "bold.italic", "black"),      
  font.xtickslab = c(12, "plain", "black"),
  legend = "top"
)

ggsurv
```

<br>
<br>

The IPASS study which was titled: "Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma" was a phase 3 clinical trial (open label).

Previously untreated East Asian patients who were suffering from non–small-cell lung cancer (advanced pulmonary adenocarcinoma) and were either former light smokers or non-smokers were assigned randomly to be treated with either a daily dose of 250mg of gefitinib (609 subjects) or a dose of carboplatin of 5 to 6mg per mililiter per minute and a dose a 200mg per meter squared of body-surface area (608 subjects). 

The primary endpoint of the trial was the progression free survival of the subject. 

From a visual inspection it is apparent that the experimental treatment begins with a greater hazard but there is a crossing of the treatment arms at around six months after that time the control arm presents the higher hazard.

<br>
<br>

```{r, echo=FALSE, fig.cap= "Schoenfeld Plot for Mok et al. 2009 IPASS Study", warning=FALSE, message=FALSE}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

colnames(IPD.Mok.A) <- c("time", "event", "Gefitinib")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ Gefitinib, data = IPD.Mok.A) 

# Schoenfeld plot
par(mfrow=c(1,1))
plot(cox.zph(cox.model, transform = "km"), main = "Schoenfeld Individual Test p: 2e-16")
abline(h=0, col=2)

# cox.zph(cox.model)
```
The Schoenfeld residual plot is an effective method to assess the proportional hazards assumption when combined with a visual inspection of the Kaplan Meier curves and a global test of non-proportional hazards. 

<br>
<br>

```{r echo=FALSE, fig.cap="Cox Proportional Hazards Model"}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

colnames(IPD.Mok.A) <- c("time", "event", "arm")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ arm, data = IPD.Mok.A) 

# format results into data frame with global p-values
cox.model %>%
  tbl_regression(
    show_single_row = arm,
    label = arm ~ "Gefitinib vs Carboplatin-Paclitaxel",
    exponentiate = TRUE) %>%
  bold_p(t = 0.10) %>%
  bold_labels() %>%
  italicize_levels()
```

<br>
<br>

----------------------------------------------------------------------------------
  Average HR                           95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  0.965                              0.844, 1.104                   0.605   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher) Weighted Cox Proportional Hazards Model

At a given instant in time a patient recieving the Gefitinib treatment is 0.965 times as likely to die as a patient who is on the Carboplatin-Paclitaxel treatment. The 95% confidence interval was (0.844, 1.104) with p value 0.605.

<br>
<br>

----------------------------------------------------------------------------------
  $\hat{c}^{\prime} \%$                95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  49.12%                             0.458, 0.525                   0.605   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher1) Weighted Cox Proportional Hazards Model (Generalized Concordance)

With a probability of 49.12% (95% CI:45.8%, 52.5%), a patient treated with Gefitinib expected (at the baseline value) to die earlier than a patient treated with Carboplatin-Paclitaxel with p value 0.605.

<br>
<br>

```{r, echo=FALSE, fig.cap="Weights used by weighted Cox regression are plotted against time"}
knitr::include_graphics(path = "figure/mok.a.coxphw.svg")
```
In this study the increase in the censoring weights are small during the first six months of treatment, after this they begin to rise rapidly. However, it should be noted that the normalised total weight range is [0,25, 2]. 

```{r, include=FALSE}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

# Pooled Survival Function S(t-) or 1-S(t-) = S(t)
S <- survfit(Surv(time, event) ~ 1, data = IPD.Mok.A)
```

<br>
<br>

```{r, echo=FALSE}
# FH(1,0)  1-S(t-) vs t (Prentice-Wilcoxon)
plot(x = S$time, y = S$surv,
     main = "FH(1,0)  1-S(t-) vs Time (Prentice-Wilcoxon)", 
     xlab = "Time",
     ylab = "1-S(t-)",
     col = "blue")
```

<br>
<br>

```{r, echo=FALSE}
# FH(0,1) S(t) against t
plot(x = S$time, y = (1-S$surv),
     main = "FH(0,1) S(t) vs Time", 
     xlab = "Time",
     ylab = "S(t)",
     col = "blue")
```

<br>
<br>

```{r, echo=FALSE}
# Log.Rank 
plot(x = S$time, 
     y = rep(1, times = length(S$time)),
     main = "FH(0,0) Constant Function One Vs Time", 
     xlab = "Time",
     ylab = "Constant Function 1",
     col = "blue")
```

<br>
<br>

```{r, echo=FALSE}
# FH(1,1) S(t)*(1-S(t))
plot(x = S$time, 
     y = (S$surv)*(1-(S$surv)), 
     main = "FH(1,1) S(t)*(1-S(t))", 
     xlab = "Time",
     ylab = "S(t)*(1-S(t)",
     col = "blue")
```

<br>
<br>

```{r, echo=FALSE, fig.cap="Weighted Log Rank Test"}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

colnames(IPD.Mok.A) <- c("time", "event", "arm")

IPD.Mok.A$event <- ifelse(IPD.Mok.A$event == 0, 1, 0)

result <- wlr.Stat(surv=IPD.Mok.A$time, cnsr=IPD.Mok.A$event, trt= IPD.Mok.A$arm, fparam=list(rho=c(0,0,1,1), gamma=c(0,1,1,0), wlr='FH(0,1)', APPLE=NULL))

result %>% 
  kableExtra::kable(caption = "Weighted Log Rank Test")
```

<br>
<br>

```{r, echo=FALSE, include=FALSE}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

rgs <- list(c(0, 0), c(0, 1), c(1, 1), c(1, 0))

draws <- 10

IPD.Mok.A$arm <- ifelse(IPD.Mok.A$arm == 0, "control", "experimental")

IPD.Mok.A$event <- ifelse(IPD.Mok.A$event == 0, 1, 0)

result.mc <- nphsim::combo.wlr(survival = IPD.Mok.A$time, cnsr = IPD.Mok.A$event, trt = IPD.Mok.A$arm, fparam = list(rgs=rgs,draws=draws))

result.mc <- lapply(result.mc, function(x) round(x, digits = 3))
```

```{r, echo=FALSE}
as.data.frame(result.mc) %>% kableExtra::kable(caption = "Max Combo Test")
```

<br>
<br>

```{r, include=FALSE, message=FALSE}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

IPD.Mok.A$arm <- ifelse(IPD.Mok.A$arm == 0, "control", "experimental")

IPD.Mok.A$event <- ifelse(IPD.Mok.A$event == 0, 1, 0)

result.rmst <- rmst.Stat(survival = IPD.Mok.A$time, cnsr = IPD.Mok.A$event, trt = IPD.Mok.A$arm, stra = NULL, fparam = 20)

result.rmst_ <- lapply(result.rmst, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.rmst_) %>% kableExtra::kable(caption = "Restricted Mean Survival Time")
```

```{r, include=FALSE}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

result.rmst2 = rmst2(time = IPD.Mok.A$time, status = IPD.Mok.A$event, arm = IPD.Mok.A$arm, tau = 20)

result.rmst2
```

The point estimate indicated that patients on the Gefitinib treatment survive `r round(result.rmst2$unadjusted.result[1,1],1)` months longer than those on Carboplatin-Paclitaxel group on average, when following up the patients `r result.rmst2$tau` months. The 95% confidence interval was (`r round(result.rmst2$unadjusted.result[1,2],1)` to `r round(result.rmst2$unadjusted.result[1,3],1)`) with p value `r round(result.rmst2$unadjusted.result[1,4],2)`.

```{r, echo=FALSE}
source("Libraries.R")

IPD.Mok.A <- readRDS("data/IPD.Mok.A.RDS")

result.rmst2 = rmst2(time = IPD.Mok.A$time, status = IPD.Mok.A$event, arm = IPD.Mok.A$arm, tau = 20)

plot(
result.rmst2,
xlab = "Months",
ylab = "Probability",
col = "black",
col.RMST = "#E7B800", 
col.RMTL = "#2E9FDF",
density = 80,
angle = 85
)

```

<br>
<br>

\clearpage 

## Brehmer et al. 2016 Nivolumab versus Docetaxel Study: Crossing Hazards

```{r, echo=FALSE, warning=FALSE, message=FALSE, fig.cap="Kaplan–Meier curves for overall survival"}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

km_trt_fit <- survfit(Surv(time, event) ~ arm, data = IPD.Brahmer.a)

ggsurv <- ggsurvplot(
  km_trt_fit,                     # survfit object with calculated statistics.
  data = IPD.Brahmer.a,             # data used to fit survival curves.
  risk.table = TRUE,       # show risk table.
  pval = FALSE,             # show p-value of log-rank test.
  conf.int = FALSE,         # show confidence intervals for 
  # point estimates of survival curves.
  palette = c("#E7B800", "#2E9FDF"),
  xlim = c(0,25),         # present narrower X axis, but not affect
  # survival estimates.
  xlab = "Months",   # customize X axis label.
  ylab = "Overall Survival (% of patients)",   # customize X axis label.
  break.time.by = 3,     # break X axis in time intervals by 500.
  ggtheme = theme_light(), # customize plot and risk table with a theme.
  risk.table.y.text.col = T,# colour risk table text annotations.
  risk.table.height = 0.25, # the height of the risk table
  risk.table.y.text = FALSE,# show bars instead of names in text annotations
  # in legend of risk table.
  ncensor.plot = FALSE,      # plot the number of censored subjects at time t
  ncensor.plot.height = 0.25,
  conf.int.style = "step",  # customize style of confidence intervals
  surv.median.line = "hv",  # add the median survival pointer.
  legend.labs = c("Docetaxel","Nivolumab")    # change legend labels.
)

# Labels for Survival Curves (plot)
ggsurv$plot <- ggsurv$plot + labs(
  title    = "Kaplan-Meier Curves for overall survival"                
  # subtitle = "Overall Survival (% of patients)"
)

# Changing the font size, style and color

ggsurv <- ggpar(
  ggsurv,
  font.title    = c(16, "bold", "black"),         
  font.subtitle = c(10, "bold.italic", "black"), 
  font.caption  = c(14, "plain", "black"),        
  font.x        = c(14, "bold.italic", "black"),          
  font.y        = c(14, "bold.italic", "black"),      
  font.xtickslab = c(12, "plain", "black"),
  legend = "top"
)

ggsurv
```

<br>
<br>

```{r, echo=FALSE}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

colnames(IPD.Brahmer.a) <- c("time", "event", "Nivolumab")

cox.model <- coxph(Surv(time, event) ~ Nivolumab, data = IPD.Brahmer.a) 

# Schoenfeld plot
par(mfrow=c(1,1))
plot(cox.zph(cox.model), main = "Schoenfeld Individual Test p: 0.002")
abline(h=0, col=2)
```

<br>
<br>

```{r echo=FALSE, fig.cap="Cox Proportional Hazards Model"}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

colnames(IPD.Brahmer.a) <- c("time", "event", "arm")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ arm, data = IPD.Brahmer.a) 

# format results into data frame with global p-values
cox.model %>%
  tbl_regression(
    show_single_row = arm,
    label = arm ~ "Nivolumab vs Docetaxel",
    exponentiate = TRUE) %>%
  bold_p(t = 0.10) %>%
  bold_labels() %>%
  italicize_levels()
```

<br>
<br>

----------------------------------------------------------------------------------
  Average HR                           95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  0.846                              0.691, 1.0348                  0.104   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher) Weighted Cox Proportional Hazards Model

At a given instant in time a patient recieving the Nivolumab treatment is 0.846 times as likely to die as a patient who is on the Docetaxel treatment. The 95% confidence interval was (0.691, 1.0348) with p value 0.104.

<br>
<br>

----------------------------------------------------------------------------------
  $\hat{c}^{\prime} \%$                95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  45.82%                             40.87, 50.85                   0.104   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher1) Weighted Cox Proportional Hazards Model (Generalized Concordance)

With a probability of 45.82% (95% CI:45.8%, 52.5%), a patient treated with Nivolumab expected (at the baseline value) to die earlier than a patient treated with Docetaxel with p value 0.104.

<br>
<br>

```{r, echo=FALSE, fig.cap="Weights used by weighted Cox regression are plotted against time"}
knitr::include_graphics(path = "figure/brehmer.coxphw.svg")
```
In this study the increase in the censoring weights are small during the first nine months of treatment, after this they begin to rise rapidly. However, it should be noted that the normalised total weight range is [1, 2]. 

<br>
<br>

```{r, echo=FALSE, fig.cap="Weighted Log Rank Test"}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

IPD.Brahmer.a$event <- ifelse(IPD.Brahmer.a$event == 0, 1, 0)

colnames(IPD.Brahmer.a) <- c("time", "event", "arm")

result <- wlr.Stat(surv=IPD.Brahmer.a$time, cnsr=IPD.Brahmer.a$event, trt= IPD.Brahmer.a$arm, fparam=list(rho=c(0,0,1,1), gamma=c(0,1,1,0), wlr='FH(0,1)', APPLE=NULL))

result %>% 
  kableExtra::kable()
```

<br>
<br>

```{r, echo=FALSE, message=FALSE, warning=FALSE, include=FALSE}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

IPD.Brahmer.a$event <- ifelse(IPD.Brahmer.a$event == 0, 1, 0)

IPD.Brahmer.a$arm <- ifelse(IPD.Brahmer.a$arm == 0, "control", "experimental")

rgs <- list(c(0, 0), c(0, 1), c(1, 1), c(1, 0))

draws <- 10

result.mc <- nphsim::combo.wlr(survival = IPD.Brahmer.a$time, cnsr = IPD.Brahmer.a$event, trt = IPD.Brahmer.a$arm, fparam = list(rgs=rgs,draws=draws))

result.mc <- lapply(result.mc, function(x) round(x, digits = 3))
```

```{r, echo=FALSE}
as.data.frame(result.mc) %>% kableExtra::kable()
```

<br>
<br>

```{r, include=FALSE, message=FALSE}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

IPD.Brahmer.a$arm <- ifelse(IPD.Brahmer.a$arm == 0, "control", "experimental")

IPD.Brahmer.a$event <- ifelse(IPD.Brahmer.a$event == 0, 1, 0)

result.rmst <- rmst.Stat(survival = IPD.Brahmer.a$time, cnsr = IPD.Brahmer.a$event, trt = IPD.Brahmer.a$arm, stra = NULL, fparam = 25)

result.rmst_ <- lapply(result.rmst, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.rmst_) %>% kableExtra::kable()
```

```{r, include=FALSE}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

result.rmst2 = rmst2(time = IPD.Brahmer.a$time, status = IPD.Brahmer.a$event, arm = IPD.Brahmer.a$arm, tau = 25)

result.rmst2
```

The point estimate indicated that patients on the Nivolumab treatment survive `r round(result.rmst2$unadjusted.result[1,1],1)` months longer than those on Docetaxel group on average, when following up the patients `r round(result.rmst2$tau, 0)` months. The 95% confidence interval was (`r round(result.rmst2$unadjusted.result[1,2],1)` to `r round(result.rmst2$unadjusted.result[1,3],1)`) with p value `r round(result.rmst2$unadjusted.result[1,4],2)`.

```{r, echo=FALSE}
source("Libraries.R")

IPD.Brahmer.a <- readRDS("data/IPD.Brahmer.a.RDS")

result.rmst2 = rmst2(time = IPD.Brahmer.a$time, status = IPD.Brahmer.a$event, arm = IPD.Brahmer.a$arm, tau = 25)

plot(
result.rmst2,
xlab = "Months",
ylab = "Probability",
col = "black",
col.RMST = "#E7B800", 
col.RMTL = "#2E9FDF",
density = 80,
angle = 85
)
```

<br>
<br>

\clearpage 

## Mok et al. 2009 IPASS Study: Dimishing Treatment Effect

```{r, echo = FALSE, fig.cap="Patients with unknown EGFR mutation status", warning=FALSE, message=FALSE}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

km_trt_fit <- survfit(Surv(time, event) ~ arm, data = IPD.Mok.C)

ggsurv <- ggsurvplot(
  km_trt_fit,                     # survfit object with calculated statistics.
  data = IPD.Mok.C,             # data used to fit survival curves.
  risk.table = TRUE,       # show risk table.
  pval = FALSE,             # show p-value of log-rank test.
  conf.int = FALSE,         # show confidence intervals for 
  # point estimates of survival curves.
  palette = c("#E7B800", "#2E9FDF"),
  xlim = c(0,12),         # present narrower X axis, but not affect
  # survival estimates.
  xlab = "Months since Randomization",   # customize X axis label.
  ylab = "Pr of Progression-free Survival",   # customize X axis label.
  break.time.by = 4,     # break X axis in time intervals by 500.
  ggtheme = theme_light(), # customize plot and risk table with a theme.
  risk.table.y.text.col = T,# colour risk table text annotations.
  risk.table.height = 0.25, # the height of the risk table
  risk.table.y.text = FALSE,# show bars instead of names in text annotations
  # in legend of risk table.
  ncensor.plot = FALSE,      # plot the number of censored subjects at time t
  ncensor.plot.height = 0.25,
  conf.int.style = "step",  # customize style of confidence intervals
  surv.median.line = "hv",  # add the median survival pointer.
  legend.labs = c("Carboplatin", "Gefitinib")    # change legend labels.
)

# Labels for Survival Curves (plot)
ggsurv$plot <- ggsurv$plot + labs(
  title    = "Kaplan-Meier Curves for Progression-free Survival",                  
  subtitle = "Patients with unknown EGFR mutation status"
)

# Changing the font size, style and color

ggsurv <- ggpar(
  ggsurv,
  font.title    = c(16, "bold", "black"),         
  font.subtitle = c(10, "bold.italic", "black"), 
  font.caption  = c(14, "plain", "black"),        
  font.x        = c(14, "bold.italic", "black"),          
  font.y        = c(14, "bold.italic", "black"),      
  font.xtickslab = c(12, "plain", "black"),
  legend = "top"
)

ggsurv
```

<br>
<br>

```{r, echo=FALSE}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

colnames(IPD.Mok.C) <- c("time", "event", "Gefitinib")

cox.model <- coxph(Surv(time, event) ~ Gefitinib, data = IPD.Mok.C) 

# Schoenfeld plot
par(mfrow=c(1,1))
plot(cox.zph(cox.model), main = "Schoenfeld Individual Test p: 0.00")
abline(h=0, col=2)
```

<br>
<br>

```{r echo=FALSE, fig.cap="Cox Proportional Hazards Model"}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

colnames(IPD.Mok.C) <- c("time", "event", "arm")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ arm, data = IPD.Mok.C) 

# format results into data frame with global p-values
cox.model %>%
  tbl_regression(
    show_single_row = arm,
    label = arm ~ "Gefitinib vs Carboplatin-Paclitaxel",
    exponentiate = TRUE) %>%
  bold_p(t = 0.10) %>%
  bold_labels() %>%
  italicize_levels()
```

<br>
<br>

----------------------------------------------------------------------------------
  Average HR                           95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  3.863                              2.699   5.531                   0.000   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher) Weighted Cox Proportional Hazards Model

At a given instant in time a patient recieving the Nivolumab treatment is 3.863 times as likely to die as a patient who is on the Docetaxel treatment. The 95% confidence interval was (2.699, 5.531) with p value 0.00 .

<br>
<br>

----------------------------------------------------------------------------------
  $\hat{c}^{\prime} \%$                95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  79.44%                             72.96, 84.69                   0.000    
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher1) Weighted Cox Proportional Hazards Model (Generalized Concordance)

With a probability of 79.44% (95% CI:72.96%, 84.69%), a patient treated with Gefitinib expected (at the baseline value) to die earlier than a patient treated with Carboplatin-Paclitaxel with p value 0.000.

<br>
<br>

```{r, echo=FALSE, fig.cap="Weights used by weighted Cox regression are plotted against time"}
knitr::include_graphics(path = "figure/mok.c.coxph.svg")
```
In this study the increase in the censoring weights are large during the course of the treatment. However, it should be noted that the normalised total weight range is [0, 2]. 

<br>
<br>

```{r, echo=FALSE, fig.cap="Weighted Log Rank Test"}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

IPD.Mok.C$event <- ifelse(IPD.Mok.C$event == 0, 1, 0)

IPD.Mok.C$arm <- ifelse(IPD.Mok.C$arm == 1, "control", "experimental")

colnames(IPD.Mok.C) <- c("time", "event", "arm")

result <- wlr.Stat(surv=IPD.Mok.C$time, cnsr=IPD.Mok.C$event, trt= IPD.Mok.C$arm, fparam=list(rho=c(0,0,1,1), gamma=c(0,1,1,0), wlr='FH(0,1)', APPLE=NULL))

result %>% 
  kableExtra::kable()
```

<br>
<br>

```{r, echo=FALSE, include=FALSE}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

rgs <- list(c(0, 0), c(0, 1), c(1, 1), c(1, 0))

draws <- 10

IPD.Mok.C$event <- ifelse(IPD.Mok.C$event == 0, 1, 0)

IPD.Mok.C$arm <- ifelse(IPD.Mok.C$arm == 1, "control", "experimental")

result.mc <- nphsim::combo.wlr(survival = IPD.Mok.C$time, cnsr = IPD.Mok.C$event, trt = IPD.Mok.C$arm, fparam = list(rgs=rgs,draws=draws))

result.mc <- lapply(result.mc, function(x) round(x, digits = 3))
```

```{r, echo=FALSE}
as.data.frame(result.mc) %>% kableExtra::kable()
```

<br>
<br>
  
```{r, include=FALSE, message=FALSE}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

IPD.Mok.C$arm <- ifelse(IPD.Mok.C$arm == 0, "control", "experimental")

IPD.Mok.C$event <- ifelse(IPD.Mok.C$event == 0, 1, 0)

result.rmst <- rmst.Stat(survival = IPD.Mok.C$time, cnsr = IPD.Mok.C$event, trt = IPD.Mok.C$arm, stra = NULL, fparam = 12)

result.rmst_ <- lapply(result.rmst, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.rmst_) %>% kableExtra::kable()
```

```{r, include=FALSE}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

result.rmst2 = rmst2(time = IPD.Mok.C$time, status = IPD.Mok.C$event, arm = IPD.Mok.C$arm, tau = 12)

result.rmst2
```

The point estimate indicated that patients on the Gefitinib treatment survive `r round(result.rmst2$unadjusted.result[1,1],1)` months longer than those on Carboplatin-Paclitaxel group on average, when following up the patients `r result.rmst2$tau` months. The 95% confidence interval was (`r round(result.rmst2$unadjusted.result[1,2],1)` to `r round(result.rmst2$unadjusted.result[1,3],1)`) with p value `r round(result.rmst2$unadjusted.result[1,4],1)`.

```{r, echo=FALSE}
source("Libraries.R")

IPD.Mok.C <- readRDS("data/IPD.Mok.C.RDS")

result.rmst2 = rmst2(time = IPD.Mok.C$time, status = IPD.Mok.C$event, arm = IPD.Mok.C$arm, tau = 12)

plot(
result.rmst2,
xlab = "Months",
ylab = "Probability",
col = "black",
col.RMST = "#E7B800", 
col.RMTL = "#2E9FDF",
density = 80,
angle = 85
)
```

<br>
<br>

\clearpage 

## Ohtsu et al. 2011 AVAGAST Study: Dimishing Treatment Effect

```{r, echo=FALSE, fig.cap="Patients in the intention-to-treat population", warning=FALSE, message=FALSE}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

km_trt_fit <- survfit(Surv(time, event) ~ arm, data = IPD.Ohtsu)

ggsurv <- ggsurvplot(
  km_trt_fit,               # survfit object with calculated statistics.
  data = IPD.Ohtsu,         # data used to fit survival curves.
  risk.table = TRUE,        # show risk table.
  pval = FALSE,             # show p-value of log-rank test.
  conf.int = FALSE,         # show confidence intervals for 
  # point estimates of survival curves.
  palette = c("#E7B800", "#2E9FDF"),
  xlim = c(0,21),         # present narrower X axis, but not affect
  # survival estimates.
  xlab = "Months since Randomization",   # customize X axis label.
  ylab = "Survival (probability)",   # customize X axis label.
  break.time.by = 3,     # break X axis in time intervals by 500.
  ggtheme = theme_light(), # customize plot and risk table with a theme.
  risk.table.y.text.col = T,# colour risk table text annotations.
  risk.table.height = 0.25, # the height of the risk table
  risk.table.y.text = FALSE,# show bars instead of names in text annotations
  # in legend of risk table.
  ncensor.plot = FALSE,      # plot the number of censored subjects at time t
  ncensor.plot.height = 0.25,
  conf.int.style = "step",  # customize style of confidence intervals
  surv.median.line = "hv",  # add the median survival pointer.
  legend.labs = c("Placebo", "Bevacizumab")    # change legend labels.
)

# Labels for Survival Curves (plot)
ggsurv$plot <- ggsurv$plot + labs(
  title    = "Kaplan-Meier estimates of overall survival",                  
  subtitle = "Patients in the intention-to-treat population"
)

# Changing the font size, style and color

ggsurv <- ggpar(
  ggsurv,
  font.title    = c(16, "bold", "black"),         
  font.subtitle = c(10, "bold.italic", "black"), 
  font.caption  = c(14, "plain", "black"),        
  font.x        = c(14, "bold.italic", "black"),          
  font.y        = c(14, "bold.italic", "black"),      
  font.xtickslab = c(12, "plain", "black"),
  legend = "top"
)

ggsurv
```

<br>
<br>

```{r, echo=FALSE}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

colnames(IPD.Ohtsu) <- c("time", "event", "Bevacizumab")

cox.model <- coxph(Surv(time, event) ~ Bevacizumab, data = IPD.Ohtsu) 

# Schoenfeld plot
par(mfrow=c(1,1))
plot(cox.zph(cox.model), main = "Schoenfeld Individual Test p: 0.0139")
abline(h=0, col=2)
```

<br>
<br>

```{r, echo=FALSE, fig.cap="Cox Proportional Hazards Model"}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

colnames(IPD.Ohtsu) <- c("time", "event", "arm")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ arm, data = IPD.Ohtsu) 

# format results into data frame with global p-values
cox.model %>%
  tbl_regression(
    show_single_row = arm,
    label = arm ~ "Bevacizumab vs Placebo",
    exponentiate = TRUE) %>%
  bold_p(t = 0.10) %>%
  bold_labels() %>%
  italicize_levels()
```

<br>
<br>

----------------------------------------------------------------------------------
  Average HR                           95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  0.852                              0.716, 1.015                   0.073  
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher) Weighted Cox Proportional Hazards Model

At a given instant in time a patient recieving the Nivolumab treatment is 0.852 times as likely to die as a patient who is on the Docetaxel treatment. The 95% confidence interval was (0.716, 1.015) with p value 0.073.

<br>
<br>

----------------------------------------------------------------------------------
  $\hat{c}^{\prime} \%$                95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  46.01%                            41.71, 50.37                   0.073   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher1) Weighted Cox Proportional Hazards Model (Generalized Concordance)

With a probability of 46.01% (95% CI:41.71%, 50.37%), a patient treated with Gefitinib expected (at the baseline value) to die earlier than a patient treated with Carboplatin-Paclitaxel with p value 0.073.

<br>
<br>

```{r, echo=FALSE, fig.cap="Weights used by weighted Cox regression are plotted against time"}
knitr::include_graphics(path = "figure/ohtsu.coxphw.svg")
```
In this study the increase in the censoring weights are small during the first 12 months of treatment, after this they begin to rise rapidly. However, it should be noted that the normalised total weight range is [1,25, 2]. 

<br>
<br>

```{r, echo=FALSE, fig.cap="Weighted Log Rank Test"}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

IPD.Ohtsu$event <- ifelse(IPD.Ohtsu$event == 0, 1, 0)

colnames(IPD.Ohtsu) <- c("time", "event", "arm")

result <- wlr.Stat(surv=IPD.Ohtsu$time, cnsr=IPD.Ohtsu$event, trt= IPD.Ohtsu$arm, fparam=list(rho=c(0,0,1,1), gamma=c(0,1,1,0), wlr='FH(0,1)', APPLE=NULL))

result %>% 
  kableExtra::kable()
```

<br>
<br>

```{r, echo=FALSE, include=FALSE}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

IPD.Ohtsu$event <- ifelse(IPD.Ohtsu$event == 0, 1, 0)

IPD.Ohtsu$arm <- ifelse(IPD.Ohtsu$arm == 0, "control", "experimental")

rgs <- list(c(0, 0), c(0, 1), c(1, 0), c(1, 1))

draws <- 10

result.mc <- nphsim::combo.wlr(survival = IPD.Ohtsu$time, cnsr = IPD.Ohtsu$event, trt = IPD.Ohtsu$arm, fparam = list(rgs=rgs,draws=draws))

result.mc <- lapply(result.mc, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.mc) %>% kableExtra::kable()
```

<br>
<br>
  
```{r, include=FALSE, message=FALSE}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

IPD.Ohtsu$arm <- ifelse(IPD.Ohtsu$arm == 0, "control", "experimental")

IPD.Ohtsu$event <- ifelse(IPD.Ohtsu$event == 0, 1, 0)

result.rmst <- rmst.Stat(survival = IPD.Ohtsu$time, cnsr = IPD.Ohtsu$event, trt = IPD.Ohtsu$arm, stra = NULL, fparam = 22)

result.rmst_ <- lapply(result.rmst, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.rmst_) %>% kableExtra::kable()
```

```{r, include=FALSE}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

result.rmst2 = rmst2(time = IPD.Ohtsu$time, status = IPD.Ohtsu$event, arm = IPD.Ohtsu$arm, tau = 22)

result.rmst2
```

The point estimate indicated that patients on the Gefitinib treatment survive `r round(result.rmst2$unadjusted.result[1,1],1)` months longer than those on Carboplatin-Paclitaxel group on average, when following up the patients `r result.rmst2$tau` months. The 95% confidence interval was (`r round(result.rmst2$unadjusted.result[1,2],1)` to `r round(result.rmst2$unadjusted.result[1,3],1)`) with p value `r round(result.rmst2$unadjusted.result[1,4],1)`.

```{r, echo=FALSE}
source("Libraries.R")

IPD.Ohtsu <- readRDS("data/IPD.Ohtsu.RDS")

result.rmst2 = rmst2(time = IPD.Ohtsu$time, status = IPD.Ohtsu$event, arm = IPD.Ohtsu$arm, tau = 22)

plot(
result.rmst2,
xlab = "Months",
ylab = "Probability",
col = "black",
col.RMST = "#E7B800", 
col.RMTL = "#2E9FDF",
density = 80,
angle = 85
)
```

<br>
<br>

\clearpage 

## Ascierto et al. 2017 The Ipilimumab Study: Delayed Treatment Effect

```{r, echo=FALSE, fig.cap="Patients in the intention-to-treat population", warning=FALSE, message=FALSE}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

km_trt_fit <- survfit(Surv(time, event) ~ arm, data = IPD.ascierto.2.a)

ggsurv <- ggsurvplot(
  km_trt_fit,               # survfit object with calculated statistics.
  data = IPD.ascierto.2.a,  # data used to fit survival curves.
  risk.table = TRUE,        # show risk table.
  pval = FALSE,             # show p-value of log-rank test.
  conf.int = FALSE,         # show confidence intervals for 
  # point estimates of survival curves.
  palette = c("#E7B800", "#2E9FDF"),
  xlim = c(0,45),         # present narrower X axis, but not affect
  # survival estimates.
  xlab = "Time since randomisation (months)",   # customize X axis label.
  ylab = "Overall survival (%)",   # customize X axis label.
  break.time.by = 3,     # break X axis in time intervals by 500.
  ggtheme = theme_light(), # customize plot and risk table with a theme.
  risk.table.y.text.col = T,# colour risk table text annotations.
  risk.table.height = 0.25, # the height of the risk table
  risk.table.y.text = FALSE,# show bars instead of names in text annotations
  # in legend of risk table.
  ncensor.plot = FALSE,      # plot the number of censored subjects at time t
  ncensor.plot.height = 0.25,
  conf.int.style = "step",  # customize style of confidence intervals
  surv.median.line = "hv",  # add the median survival pointer.
  legend.labs = c("3mg", "10mg")    # change legend labels.
)

# Labels for Survival Curves (plot)
ggsurv$plot <- ggsurv$plot + labs(
  title    = "Kaplan-Meier Curves for Over-all Survival",                  
  subtitle = "Overall survival in the intention-to-treat population."
)

# Changing the font size, style and color

ggsurv <- ggpar(
  ggsurv,
  font.title    = c(16, "bold", "black"),         
  font.subtitle = c(10, "bold.italic", "black"), 
  font.caption  = c(14, "plain", "black"),        
  font.x        = c(14, "bold.italic", "black"),          
  font.y        = c(14, "bold.italic", "black"),      
  font.xtickslab = c(12, "plain", "black"),
  legend = "top"
)

ggsurv
```

<br>
<br>

```{r, echo=FALSE, message=FALSE, warning=FALSE}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

colnames(IPD.ascierto.2.a) <- c("time", "event", "10mg")

cox.model <- coxph(Surv(time, event) ~ IPD.ascierto.2.a$`10mg`, data = IPD.ascierto.2.a) 

# Schoenfeld plot
par(mfrow=c(1,1))
plot(cox.zph(cox.model), main = "Schoenfeld Individual Test p: 0.1812")
abline(h=0, col=2)
```

<br>
<br>

```{r echo=FALSE, fig.cap="Cox Proportional Hazards Model"}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

colnames(IPD.ascierto.2.a) <- c("time", "event", "arm")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ arm, data = IPD.ascierto.2.a) 

# format results into data frame with global p-values
cox.model %>%
  tbl_regression(
    show_single_row = arm,
    label = arm ~ "10mg vs 3mg",
    exponentiate = TRUE) %>%
  bold_p(t = 0.10) %>%
  bold_labels() %>%
  italicize_levels()
```

<br>
<br>

----------------------------------------------------------------------------------
  Average HR                           95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  0.884                              0.739, 1.058                   0.179   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher) Weighted Cox Proportional Hazards Model

At a given instant in time a patient recieving the Nivolumab treatment is 0.846 times as likely to die as a patient who is on the Docetaxel treatment. The 95% confidence interval was (0.691, 1.0348) with p value 0.179.

<br>
<br>

----------------------------------------------------------------------------------
  $\hat{c}^{\prime} \%$                95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  46.93%                             42.5, 51.41                   0.179   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher1) Weighted Cox Proportional Hazards Model (Generalized Concordance)

With a probability of 46.93% (95% CI:42.5%, 51.41%), a patient treated with Gefitinib expected (at the baseline value) to die earlier than a patient treated with Carboplatin-Paclitaxel with p value 0.179.

<br>
<br>

```{r, echo=FALSE, fig.cap="Weights used by weighted Cox regression are plotted against time"}
knitr::include_graphics(path = "figure/asc.coxphw.svg")
```
In this study the increase in the censoring weights are large during the first 3 months of treatment, after this they begin to rise slowly until after 40 months and then increase very quickly. However, it should be noted that the normalised total weight range is [0.5, 1.75]. 

<br>
<br>

```{r, echo=FALSE, fig.cap="Weighted Log Rank Test"}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

IPD.ascierto.2.a$event <- ifelse(IPD.ascierto.2.a$event == 0, 1, 0)

colnames(IPD.ascierto.2.a) <- c("time", "event", "arm")

result <- wlr.Stat(surv=IPD.ascierto.2.a$time, cnsr=IPD.ascierto.2.a$event, trt= IPD.ascierto.2.a$arm, fparam=list(rho=c(0,0,1,1), gamma=c(0,1,1,0), wlr='FH(0,1)', APPLE=NULL))

result %>% 
  kableExtra::kable()
```

<br>
<br>

```{r, echo=FALSE, include=FALSE}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

rgs <- list(c(0, 0), c(0, 1), c(1, 1), c(1, 0))

draws <- 10

IPD.ascierto.2.a$event <- ifelse(IPD.ascierto.2.a$event == 0, 1, 0)

IPD.ascierto.2.a$arm <- ifelse(IPD.ascierto.2.a$arm == 0, "control", "experimental")

result.mc <- nphsim::combo.wlr(survival = IPD.ascierto.2.a$time, cnsr = IPD.ascierto.2.a$event, trt = IPD.ascierto.2.a$arm, fparam = list(rgs=rgs,draws=draws))

result.mc <- lapply(result.mc, function(x) round(x, digits = 3))
```

```{r, echo=FALSE}
as.data.frame(result.mc) %>% kableExtra::kable()
```

<br>
<br>
  
```{r, include=FALSE, message=FALSE}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

IPD.ascierto.2.a$arm <- ifelse(IPD.ascierto.2.a$arm == 0, "control", "experimental")

IPD.ascierto.2.a$event <- ifelse(IPD.ascierto.2.a$event == 0, 1, 0)

result.rmst <- rmst.Stat(survival = IPD.ascierto.2.a$time, cnsr = IPD.ascierto.2.a$event, trt = IPD.ascierto.2.a$arm, stra = NULL, fparam = 45)

result.rmst_ <- lapply(result.rmst, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.rmst_) %>% kableExtra::kable()
```

```{r, include=FALSE}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

result.rmst2 = rmst2(time = IPD.ascierto.2.a$time, status = IPD.ascierto.2.a$event, arm = IPD.ascierto.2.a$arm, tau = 45)

result.rmst2
```

The point estimate indicated that patients on the Ipilimumab 10 mg/kg treatment survive `r round(result.rmst2$unadjusted.result[1,1],1)` months longer than those on Ipilimumab 3 mg/kg group on average, when following up the patients `r result.rmst2$tau` months. The 95% confidence interval was (`r round(result.rmst2$unadjusted.result[1,2],1)` to `r round(result.rmst2$unadjusted.result[1,3],1)`) with p value `r round(result.rmst2$unadjusted.result[1,4],1)`.

```{r, echo=FALSE}
source("Libraries.R")

IPD.ascierto.2.a <- readRDS("data/IPD.ascierto.2.a.RDS")

result.rmst2 = rmst2(time = IPD.ascierto.2.a$time, status = IPD.ascierto.2.a$event, arm = IPD.ascierto.2.a$arm, tau = 45)

plot(
result.rmst2,
xlab = "Months",
ylab = "Probability",
col = "black",
col.RMST = "#E7B800", 
col.RMTL = "#2E9FDF",
density = 80,
angle = 85
)
```

<br>
<br>

\clearpage 

## Rittermeyer et al. 2017 The OAK Study: Delayed Treatment Effect

```{r, echo = FALSE, fig.cap="Patients in the WT population", warning=FALSE, message=FALSE}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

km_trt_fit <- survfit(Surv(time, event) ~ arm, data = IPD.Rittmeyer)

ggsurv <- ggsurvplot(
  km_trt_fit,               # survfit object with calculated statistics.
  data = IPD.Rittmeyer,     # data used to fit survival curves.
  risk.table = TRUE,        # show risk table.
  pval = FALSE,             # show p-value of log-rank test.
  conf.int = FALSE,         # show confidence intervals for 
  # point estimates of survival curves.
  palette = c("#E7B800", "#2E9FDF"),
  xlim = c(0,26),         # present narrower X axis, but not affect
  # survival estimates.
  xlab = "Months since Randomization",   # customize X axis label.
  ylab = "Pr of Progression-free Survival",   # customize X axis label.
  break.time.by = 2,     # break X axis in time intervals by 500.
  ggtheme = theme_light(), # customize plot and risk table with a theme.
  risk.table.y.text.col = T,# colour risk table text annotations.
  risk.table.height = 0.25, # the height of the risk table
  risk.table.y.text = FALSE,# show bars instead of names in text annotations
  # in legend of risk table.
  ncensor.plot = FALSE,      # plot the number of censored subjects at time t
  ncensor.plot.height = 0.25,
  conf.int.style = "step",  # customize style of confidence intervals
  surv.median.line = "hv",  # add the median survival pointer.
  legend.labs = c("Docetaxel","Atezolizumab")    # change legend labels.
)

# Labels for Survival Curves (plot)
ggsurv$plot <- ggsurv$plot + labs(
  title    = "Kaplan Meier Estimates of Progression-free Survival",                  
  subtitle = "Patients in the IIT population"
)

# Changing the font size, style and color

ggsurv <- ggpar(
  ggsurv,
  font.title    = c(16, "bold", "black"),         
  font.subtitle = c(10, "bold.italic", "black"), 
  font.caption  = c(14, "plain", "black"),        
  font.x        = c(14, "bold.italic", "black"),          
  font.y        = c(14, "bold.italic", "black"),      
  font.xtickslab = c(12, "plain", "black"),
  legend = "top"
)

ggsurv
```

<br>
<br>

```{r, echo=FALSE, message=FALSE, warning=FALSE}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

colnames(IPD.Rittmeyer) <- c("time", "event", "Atezolizumab")

cox.model <- coxph(Surv(time, event) ~ IPD.Rittmeyer$`Atezolizumab`, data = IPD.Rittmeyer) 

# Schoenfeld plot
par(mfrow=c(1,1))
plot(cox.zph(cox.model), main = "Schoenfeld Individual Test p: 0.3971")
abline(h=0, col=2)
```

<br>
<br>

```{r echo=FALSE, fig.cap="Cox Proportional Hazards Model"}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

colnames(IPD.Rittmeyer) <- c("time", "event", "arm")

# fit coxph model
cox.model <- coxph(Surv(time, event) ~ arm, data = IPD.Rittmeyer) 

# format results into data frame with global p-values
cox.model %>%
  tbl_regression(
    show_single_row = arm,
    label = arm ~ "Atezolizumab versus Docetaxel",
    exponentiate = TRUE) %>%
  bold_p(t = 0.10) %>%
  bold_labels() %>%
  italicize_levels()
```

<br>
<br>

----------------------------------------------------------------------------------
  Average HR                           95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  0.728                              0.614, 0.863                   0.000   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher) Weighted Cox Proportional Hazards Model

At a given instant in time a patient recieving the Atezolizumab treatment is 0.0.728 times as likely to die as a patient who is on the Docetaxel treatment. The 95% confidence interval was (0.614, 0.863) with p value 0.000.

<br>
<br>

----------------------------------------------------------------------------------
  $\hat{c}^{\prime} \%$                95% CI	                      p-value
------------------------- ---------------------------------- ---------------------
  42.13%                            38.05, 46.31                     0.000   
------------------------- ---------------------------------- ---------------------
Table: (\#tab:inher1) Weighted Cox Proportional Hazards Model (Generalized Concordance)

With a probability of 49.12% (95% CI:45.8%, 52.5%), a patient treated with Gefitinib expected (at the baseline value) to die earlier than a patient treated with Carboplatin-Paclitaxel with p value 0.000.

<br>
<br>

```{r, echo=FALSE, fig.cap="Weights used by weighted Cox regression are plotted against time"}
knitr::include_graphics(path = "figure/ritt.coxphw.svg")
```
In this study the increase in the censoring weights are small during the first 18 months of treatment, after this they begin to rise rapidly. However, it should be noted that the normalised total weight range is [1.5, 2]. 

<br>
<br>

```{r, echo=FALSE, fig.cap="Weighted Log Rank Test"}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

IPD.Rittmeyer$event <- ifelse(IPD.Rittmeyer$event == 0, 1, 0)

colnames(IPD.Rittmeyer) <- c("time", "event", "arm")

result <- wlr.Stat(surv=IPD.Rittmeyer$time, cnsr=IPD.Rittmeyer$event, trt= IPD.Rittmeyer$arm, fparam=list(rho=c(0,0,1,1), gamma=c(0,1,1,0), wlr='FH(0,1)', APPLE=NULL))

result %>% 
  kableExtra::kable()
```

<br>
<br>

```{r, echo=FALSE, include=FALSE}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

IPD.Rittmeyer$event <- ifelse(IPD.Rittmeyer$event == 0, 1, 0)

IPD.Rittmeyer$arm <- ifelse(IPD.Rittmeyer$arm == 0, "control", "experimental")

rgs <- list(c(0, 0), c(0, 1), c(1, 1), c(1, 0))

draws <- 10

result.mc <- nphsim::combo.wlr(survival = IPD.Rittmeyer$time, cnsr = IPD.Rittmeyer$event, trt = IPD.Rittmeyer$arm, fparam = list(rgs=rgs,draws=draws))

result.mc <- lapply(result.mc, function(x) round(x, digits = 3))
```

```{r, echo=FALSE}
as.data.frame(result.mc) %>% kableExtra::kable()
```

<br>
<br>
  
```{r, include=FALSE, message=FALSE}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

IPD.Rittmeyer$arm <- ifelse(IPD.Rittmeyer$arm == 0, "control", "experimental")

IPD.Rittmeyer$event <- ifelse(IPD.Rittmeyer$event == 0, 1, 0)

result.rmst <- rmst.Stat(survival = IPD.Rittmeyer$time, cnsr = IPD.Rittmeyer$event, trt = IPD.Rittmeyer$arm, stra = NULL, fparam = 26)

result.rmst_ <- lapply(result.rmst, function(x) round(x, digits = 5))
```

```{r, echo=FALSE}
as.data.frame(result.rmst_) %>% kableExtra::kable()
```

```{r, include=FALSE}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

result.rmst2 = rmst2(time = IPD.Rittmeyer$time, status = IPD.Rittmeyer$event, arm = IPD.Rittmeyer$arm, tau = 26)

result.rmst2
```

The point estimate indicated that patients on the Atezolizumab treatment survive `r round(result.rmst2$unadjusted.result[1,1],1)` months longer than those on Docetaxel group on average, when following up the patients `r result.rmst2$tau` months. The 95% confidence interval was (`r round(result.rmst2$unadjusted.result[1,2],1)` to `r round(result.rmst2$unadjusted.result[1,3],1)`) with p value `r round(result.rmst2$unadjusted.result[1,4],1)`.

```{r, echo=FALSE}
source("Libraries.R")

IPD.Rittmeyer <- readRDS("data/IPD.Rittmeyer.RDS")

result.rmst2 = rmst2(time = IPD.Rittmeyer$time, status = IPD.Rittmeyer$event, arm = IPD.Rittmeyer$arm, tau = 26)

plot(
result.rmst2,
xlab = "Months",
ylab = "Probability",
col = "black",
col.RMST = "#E7B800", 
col.RMTL = "#2E9FDF",
density = 80,
angle = 85
)
```

<br>
<br>

## Tables

In addition to the tables that can be automatically generated from a data frame in **R** that you saw in [R Markdown Basics] using the `kable()` function, you can also create tables using _pandoc_. (More information is available at <https://pandoc.org/README.html#tables>.)  This might be useful if you don't have values specifically stored in **R**, but you'd like to display them in table form.  Below is an example.  Pay careful attention to the alignment in the table and hyphens to create the rows and columns.

----------------------------------------------------------------------------------
  Factors                    Correlation between Parents & Child      Inherited
------------------------- ----------------------------------------- --------------
  Education                                -0.49                         Yes
  
  Socio-Economic Status                     0.28                        Slight   
  
  Income                                    0.08                          No
  
  Family Size                               0.18                        Slight
  
  Occupational Prestige                     0.21                        Slight
------------------------- ----------------------------------------- --------------
Table: (\#tab:inher) Correlation of Inheritance Factors for Parents and Child 

We can also create a link to the table by doing the following: Table \@ref(tab:inher).  If you go back to [Loading and exploring data] and look at the `kable` table, we can create a reference to this max delays table too: Table \@ref(tab:maxdelays). The addition of the `(\#tab:inher)` option to the end of the table caption allows us to then make a reference to Table `\@ref(tab:label)`. Note that this reference could appear anywhere throughout the document after the table has appeared.  

<!-- We will next explore ways to create this label-ref link using figures. -->

\clearpage

<!-- clearpage ends the page, and also dumps out all floats.
  Floats are things like tables and figures. -->


## Figures

If your thesis has a lot of figures, _R Markdown_ might behave better for you than that other word processor.  One perk is that it will automatically number the figures accordingly in each chapter.    You'll also be able to create a label for each figure, add a caption, and then reference the figure in a way similar to what we saw with tables earlier.  If you label your figures, you can move the figures around and _R Markdown_ will automatically adjust the numbering for you.  No need for you to remember!  So that you don't have to get too far into LaTeX to do this, a couple **R** functions have been created for you to assist.  You'll see their use below.

<!--
One thing that may be annoying is the way _R Markdown_ handles "floats" like tables and figures (it's really \LaTeX's fault). \LaTeX\ will try to find the best place to put your object based on the text around it and until you're really, truly done writing you should just leave it where it lies. There are some optional arguments specified in the options parameter of the `label` function.  If you need to shift your figure around, it might be good to look here on tweaking the options argument:  <https://en.wikibooks.org/wiki/LaTeX/Floats,_Figures_and_Captions>

If you need a graphic or tabular material to be part of the text, you can just put it inline. If you need it to appear in the list of figures or tables, it should be placed in a code chunk.
-->


In the **R** chunk below, we will load in a picture stored as `reed.jpg` in our main directory.  We then give it the caption of "Reed logo", the label of "reedlogo", and specify that this is a figure.  Make note of the different **R** chunk options that are given in the R Markdown file (not shown in the knitted document).

```{r reedlogo, fig.cap="Reed logo"}
include_graphics(path = "figure/reed.jpg")
```

Here is a reference to the Reed logo: Figure \@ref(fig:reedlogo).  Note the use of the `fig:` code here.  By naming the **R** chunk that contains the figure, we can then reference that figure later as done in the first sentence here.  We can also specify the caption for the figure via the R chunk option `fig.cap`.

\clearpage 

<!-- starts a new page and stops trying to place floats such as tables and figures -->

Below we will investigate how to save the output of an **R** plot and label it in a way similar to that done above.  Recall the `flights` dataset from Chapter \@ref(rmd-basics).  (Note that we've shown a different way to reference a section or chapter here.)  We will next explore a bar graph with the mean flight departure delays by airline from Portland for 2014.

```{r delaysboxplot, warnings=FALSE, messages=FALSE, fig.cap="Mean Delays by Airline", fig.width=6}
mean_delay_by_carrier <- flights %>%
  group_by(carrier) %>%
  summarize(mean_dep_delay = mean(dep_delay))
ggplot(mean_delay_by_carrier, aes(x = carrier, y = mean_dep_delay)) +
  geom_bar(position = "identity", stat = "identity", fill = "red")
```

Here is a reference to this image: Figure \@ref(fig:delaysboxplot).

A table linking these carrier codes to airline names is available at <https://github.com/ismayc/pnwflights14/blob/master/data/airlines.csv>.

\clearpage

Next, we will explore the use of the `out.extra` chunk option, which can be used to shrink or expand an image loaded from a file by specifying `"scale= "`. Here we use the mathematical graph stored in the "subdivision.pdf" file.

```{r subd, results="asis", echo=FALSE, fig.cap="Subdiv. graph", out.extra="scale=0.75"}
include_graphics("figure/subdivision.pdf")
```

Here is a reference to this image: Figure \@ref(fig:subd).  Note that `echo=FALSE` is specified so that the **R** code is hidden in the document.

**More Figure Stuff**

Lastly, we will explore how to rotate and enlarge figures using the `out.extra` chunk option.  (Currently this only works in the PDF version of the book.)

```{r subd2, results="asis", echo=FALSE, out.extra="angle=180, scale=1.1", fig.cap="A Larger Figure, Flipped Upside Down"}
include_graphics("figure/subdivision.pdf")
```

As another example, here is a reference: Figure \@ref(fig:subd2).  

## Footnotes and Endnotes

You might want to footnote something. ^[footnote text] The footnote will be in a smaller font and placed appropriately. Endnotes work in much the same way. More information can be found about both on the CUS site or feel free to reach out to <data@reed.edu>.

## Bibliographies

Of course you will need to cite things, and you will probably accumulate an armful of sources. There are a variety of tools available for creating a bibliography database (stored with the .bib extension).  In addition to BibTeX suggested below, you may want to consider using the free and easy-to-use tool called Zotero.  The Reed librarians have created Zotero documentation at <https://libguides.reed.edu/citation/zotero>.  In addition, a tutorial is available from Middlebury College at <https://sites.middlebury.edu/zoteromiddlebury/>.

_R Markdown_ uses _pandoc_ (<https://pandoc.org/>) to build its bibliographies.  One nice caveat of this is that you won't have to do a second compile to load in references as standard LaTeX requires. To cite references in your thesis (after creating your bibliography database), place the reference name inside square brackets and precede it by the "at" symbol.  For example, here's a reference to a book about worrying:  [@Molina1994].  This `Molina1994` entry appears in a file called `thesis.bib` in the `bib` folder.  This bibliography database file was created by a program called BibTeX.  You can call this file something else if you like (look at the YAML header in the main .Rmd file) and, by default, is to placed in the `bib` folder.  

For more information about BibTeX and bibliographies, see our CUS site (<https://web.reed.edu/cis/help/latex/index.html>)^[@reedweb2007]. There are three pages on this topic:  _bibtex_ (which talks about using BibTeX, at <https://web.reed.edu/cis/help/latex/bibtex.html>), _bibtexstyles_ (about how to find and use the bibliography style that best suits your needs, at <https://web.reed.edu/cis/help/latex/bibtexstyles.html>) and _bibman_ (which covers how to make and maintain a bibliography by hand, without BibTeX, at <https://web.reed.edu/cis/help/latex/bibman.html>). The last page will not be useful unless you have only a few sources.

If you look at the YAML header at the top of the main .Rmd file you can see that we can specify the style of the bibliography by referencing the appropriate csl file.  You can download a variety of different style files at <https://www.zotero.org/styles>.  Make sure to download the file into the csl folder.  

<!-- Fill the rest of the page with the content below for the PDF version. -->

\vfill

**Tips for Bibliographies**

- Like with thesis formatting, the sooner you start compiling your bibliography for something as large as thesis, the better. Typing in source after source is mind-numbing enough; do you really want to do it for hours on end in late April? Think of it as procrastination.
- The cite key (a citation's label) needs to be unique from the other entries.
- When you have more than one author or editor, you need to separate each author's name by the word "and" e.g. `Author = {Noble, Sam and Youngberg, Jessica},`.
- Bibliographies made using BibTeX (whether manually or using a manager) accept LaTeX markup, so you can italicize and add symbols as necessary.
- To force capitalization in an article title or where all lowercase is generally used, bracket the capital letter in curly braces.
- You can add a Reed Thesis citation^[@noble2002] option. The best way to do this is to use the phdthesis type of citation, and use the optional "type" field to enter "Reed thesis" or "Undergraduate thesis." 

## Anything else?

If you'd like to see examples of other things in this template, please contact the Data @ Reed team (email <data@reed.edu>) with your suggestions. We love to see people using _R Markdown_ for their theses, and are happy to help.

